Chiesi Reports Strong FY2025 Financial and Sustainability Results and Announces Leadership Transition Highlights

Contributed by: Business Wire

Logo

Tags

Biotechnology

Professional Services

Health

Pharmaceutical

Research

Genetics

Environment

Science

Clinical Trials

Finance

Sustainability

Strong FY2025 Financial and Sustainability Results

More Like This

Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices

PR Newswire associated0

Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030

Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets

Chiesi Group Forges Alliance with Karolinska Institutet to Tackle Urgent Health Challenges

For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025

Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress

Takeda Announces FY2023 H1 Results; Updates Full-Year Forecasts While Remaining on Track Towards Management Guidance

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion